Christopher G. Chavez

This profile gathers the share dealings of Christopher G. Chavez across 3 companies, led by Endologix Inc /DE/, TriVascular Technologies, Inc. and Nuvectra Corp. Over a trading history stretching from 3 February 2016 to 21 September 2019, the count stands at 19 filings.

Sales make up the whole of the open-market record (2 sales, €79). The rest of the record consists of 4 share grants and 4 option exercises.

The record was last updated on 23 September 2019 with an option exercise (€1,340) in Nuvectra Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.